A RANDOMIZED CLINICAL TRIAL OF ANDEXANET ALFA IN ACUTE INTRACRANIAL HEMORRHAGE IN PATIENTS RECEIVING AN ORAL FACTOR XA INHIBITOR.
Datos básicos
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
PORTOLA PHARMACEUTICALS, INC.
Cita
A RANDOMIZED CLINICAL TRIAL OF ANDEXANET ALFA IN ACUTE INTRACRANIAL HEMORRHAGE IN PATIENTS RECEIVING AN ORAL FACTOR XA INHIBITOR. (18-513). PORTOLA PHARMACEUTICALS, INC. 2021-2023. IP:JOSÉ IGNACIO TEMBL FERRAIRO.
Portal de investigación